+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Tezspire Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • PDF Icon

    Report

  • 175 Pages
  • April 2025
  • Region: Global
  • The Business Research Company
  • ID: 6104007
The tezspire market research report is one of a series of new reports that provides tezspire market statistics, including tezspire industry global market size, regional shares, competitors with a tezspire market share, detailed tezspire market segments, market trends and opportunities, and any further data you may need to thrive in the tezspire industry. This tezspire market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The growth in the forecast period can be attributed to the expansion of pediatric indications, growing asthma diagnosis rates, increasing adoption of biologics in asthma care, and rising healthcare expenditure in emerging markets. Major trends in the forecast period include a shift toward biologic therapies, a focus on early intervention and prevention, a rise in subcutaneous self-administration treatments, the adoption of digital health solutions in asthma management, and greater patient-centric treatment models.

The increasing prevalence of asthma is expected to drive the growth of the tezspire market in the coming years. Asthma is a chronic respiratory condition characterized by inflammation and narrowing of the airways, causing symptoms such as difficulty breathing, wheezing, coughing, and shortness of breath. The rise in asthma cases is partly attributed to factors such as environmental pollution and lifestyle changes, which lead to greater exposure to allergens and respiratory irritants. Tezspire, a targeted biologic treatment, helps manage severe asthma by inhibiting a key protein involved in inflammation, reducing exacerbations, and providing relief for patients who do not respond to traditional therapies. For example, in November 2022, the Greater London Authority reported that more than 3,600 children were hospitalized due to asthma in London during 2021/22, marking a 64 percent increase from the previous year. This growing prevalence of asthma is driving the demand for tezspire.

The increasing number of clinical trials is also contributing to the growth of the tezspire market. Clinical trials are research studies conducted with human participants to assess the safety, effectiveness, and potential side effects of medical treatments, interventions, or devices. The rise in clinical trials is driven by advances in medical research, the growing demand for personalized treatments, and the need to evaluate new therapies for emerging health conditions. Clinical trials played a critical role in demonstrating the efficacy and safety of tezspire, leading to its approval for the treatment of severe asthma and promoting its adoption in clinical settings. For instance, in December 2024, The Association of the British Pharmaceutical Industry reported that the number of industry-sponsored clinical trials in the UK increased from 411 in 2022 to 426 in 2023. This growth in clinical trials is a key factor fueling the expansion of the tezspire market.

A significant trend in the tezspire market is the gaining of regulatory approvals for broader indications, especially in asthma and potentially other chronic inflammatory conditions. Regulatory approvals are granted by health authorities such as the FDA or EMA, allowing drugs and treatments to be marketed and used once their safety, efficacy, and quality have been established. In February 2023, AstraZeneca, in collaboration with Amgen Inc., received approval for Tezspire (tezepelumab-ekko) to be administered by self-injection using a new pre-filled pen for patients aged 12 and older with severe asthma. This approval enables patients to administer the treatment at home after proper training. The approval was based on data from the PATHFINDER clinical trial program, where a large majority of participants successfully self-administered the drug. Tezspire is notable because it is the first biologic treatment for severe asthma that does not have restrictions based on phenotype or biomarker status, offering a broader range of treatment options for patients.

The key players in the tezspire market are AstraZeneca plc, Amgen Inc.

North America was the largest region in the tezspire market in 2024. The regions covered in tezspire report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tezspire market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

Tezspire is a biologic medication designed to target and inhibit the protein thymic stromal lymphopoietin (TSLP), which plays a crucial role in the inflammatory processes associated with respiratory diseases. It is primarily used to treat severe asthma and chronic obstructive pulmonary disease (COPD), helping to reduce inflammation and improve breathing in affected patients.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The key indications for Tezspire include asthma, chronic obstructive pulmonary disease, chronic rhinosinusitis, chronic spontaneous urticaria, and eosinophilic esophagitis. Asthma is a long-term condition characterized by inflammation and narrowing of the airways, leading to difficulty breathing. Tezspire is distributed through hospital pharmacies, retail pharmacies, and online pharmacies, and is used by both adult and pediatric patients.

The tezspire market consists of the sales of monoclonal antibodies (mAbs), vaccines, and fusion proteins. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Tezspire Market Characteristics
3. Tezspire Market Biologic Drug Characteristics
3.1. Molecule Type
3.2. Route Of Administration (ROA)
3.3. Mechanism Of Action (MOA)
3.4. Safety And Efficacy
4. Tezspire Market Trends And Strategies5. Tezspire Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
6. Global Tezspire Growth Analysis And Strategic Analysis Framework
6.1. Global Tezspire PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis Of End Use Industries
6.3. Global Tezspire Market Growth Rate Analysis
6.4. Global Tezspire Historic Market Size and Growth, 2019 - 2024, Value ($ Million)
6.5. Global Tezspire Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)
6.6. Global Tezspire Total Addressable Market (TAM)
7. Global Tezspire Pricing Analysis & Forecasts
8. Tezspire Market Segmentation
8.1. Global Tezspire Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Chronic Rhinosinusitis
  • Chronic Spontaneous Urticaria
  • Eosinophilic Esophagitis
8.2. Global Tezspire Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
8.3. Global Tezspire Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Adult Patients
  • Pediatric Patients
9. Global Tezspire Epidemiology Of Clinical Indications
9.1. Drug Side Effects
9.2. Incidence And Prevalence of Clinical Indications
10. Tezspire Market Regional And Country Analysis
10.1. Global Tezspire Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
10.2. Global Tezspire Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11. Asia-Pacific Tezspire Market
11.1. Asia-Pacific Tezspire Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Tezspire Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11.3. Asia-Pacific Tezspire Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11.4. Asia-Pacific Tezspire Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
12. China Tezspire Market
12.1. China Tezspire Market Overview
12.2. China Tezspire Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
12.3. China Tezspire Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
12.4. China Tezspire Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
13. India Tezspire Market
13.1. India Tezspire Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
13.2. India Tezspire Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
13.3. India Tezspire Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14. Japan Tezspire Market
14.1. Japan Tezspire Market Overview
14.2. Japan Tezspire Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14.3. Japan Tezspire Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14.4. Japan Tezspire Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15. Australia Tezspire Market
15.1. Australia Tezspire Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15.2. Australia Tezspire Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15.3. Australia Tezspire Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16. South Korea Tezspire Market
16.1. South Korea Tezspire Market Overview
16.2. South Korea Tezspire Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16.3. South Korea Tezspire Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16.4. South Korea Tezspire Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17. Western Europe Tezspire Market
17.1. Western Europe Tezspire Market Overview
17.2. Western Europe Tezspire Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17.3. Western Europe Tezspire Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17.4. Western Europe Tezspire Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18. UK Tezspire Market
18.1. UK Tezspire Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18.2. UK Tezspire Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18.3. UK Tezspire Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19. Germany Tezspire Market
19.1. Germany Tezspire Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19.2. Germany Tezspire Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19.3. Germany Tezspire Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20. France Tezspire Market
20.1. France Tezspire Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20.2. France Tezspire Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20.3. France Tezspire Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21. Eastern Europe Tezspire Market
21.1. Eastern Europe Tezspire Market Overview
21.2. Eastern Europe Tezspire Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21.3. Eastern Europe Tezspire Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21.4. Eastern Europe Tezspire Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22. North America Tezspire Market
22.1. North America Tezspire Market Overview
22.2. North America Tezspire Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22.3. North America Tezspire Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22.4. North America Tezspire Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23. USA Tezspire Market
23.1. USA Tezspire Market Overview
23.2. USA Tezspire Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23.3. USA Tezspire Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23.4. USA Tezspire Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24. Canada Tezspire Market
24.1. Canada Tezspire Market Overview
24.2. Canada Tezspire Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24.3. Canada Tezspire Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24.4. Canada Tezspire Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25. South America Tezspire Market
25.1. South America Tezspire Market Overview
25.2. South America Tezspire Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25.3. South America Tezspire Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25.4. South America Tezspire Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26. Middle East Tezspire Market
26.1. Middle East Tezspire Market Overview
26.2. Middle East Tezspire Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26.3. Middle East Tezspire Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26.4. Middle East Tezspire Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27. Africa Tezspire Market
27.1. Africa Tezspire Market Overview
27.2. Africa Tezspire Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27.3. Africa Tezspire Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27.4. Africa Tezspire Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
28. Tezspire Market Competitive Landscape And Company Profiles
28.1. Tezspire Market Competitive Landscape
28.2. Tezspire Market Company Profiles
28.2.1. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
28.2.2. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
29. Global Tezspire Market Pipeline Analysis
29.1. High Level Clinic Trail Information
30. Global Tezspire Market Competitive Benchmarking And Dashboard31. Key Mergers And Acquisitions In The Tezspire Market32. Recent Developments In The Tezspire Market
33. Tezspire Market High Potential Countries, Segments and Strategies
33.1 Tezspire Market In 2029 - Countries Offering Most New Opportunities
33.2 Tezspire Market In 2029 - Segments Offering Most New Opportunities
33.3 Tezspire Market In 2029 - Growth Strategies
33.3.1 Market Trend Based Strategies
33.3.2 Competitor Strategies
34. Appendix
34.1. Abbreviations
34.2. Currencies
34.3. Historic And Forecast Inflation Rates
34.4. Research Inquiries
34.5. About the Analyst
34.6. Copyright And Disclaimer

Executive Summary

Tezspire Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tezspire market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for tezspire ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tezspire market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Indication: Asthma; Chronic Obstructive Pulmonary Disease; Chronic Rhinosinusitis; Chronic Spontaneous Urticaria; Eosinophilic Esophagitis
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By End User: Adult Patients; Pediatric Patients

Key Companies Profiled: AstraZeneca plc; Amgen Inc.

Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

  • AstraZeneca plc
  • Amgen Inc.